Skip to main content
SpringerLink
Log in

Synthesis, anticancer evaluation, CDK2 inhibition, and apoptotic activity assessment with molecular docking modeling of new class of pyrazolo[1,5-a]pyrimidines

  • Published:
Research on Chemical Intermediates Aims and scope Submit manuscript

Abstract

2-Cyanopyrazolo[1,5-a]pyrimidine derivative 3 reacted with some aromatic aldehydes, arenediazonium salts, hydrazine hydrate, and guanidine hydrochloride to create a series of novel pyrazolo[1,5-a]pyrimidine derivatives. Spectroscopic data confirmed the structure of the newly synthesized compounds. Some target compounds were tested in vitro for anticancer efficacy against three cancer cell lines: HepG-2, MCF-7, and Hela. On the most efficient anticancer compounds 6b,c, 6f, and 6h,i, the CDK-2 enzyme was evaluated. Using the HepG-2 cancer cell line, compounds 6b and 6i demonstrated the most effective inhibitory activity against CDK-2, with IC50 values of 0.199 ± 0.005 μg/ml and IC50 = 0.206 ± 0.007 μg/ml, respectively, compared to Dinaciclib and Roscovitine, which had IC50 values of 0.021 ± 0.002 and 0.230 ± 0.007 μg/ml, respectively. In cell cycle assay, compounds 6b, 6f and 6i arrest cell cycle at G2/M, G1/S and G2/M phases, respectively. Compound 6f has a stronger apoptosis induction effect (27.82%) than compounds 6b (7.92%) and 6i (19.21%). Also, silico studies (Molecular docking and Lipinski’s rules) for compounds 6b, 6f and 6i were carried out.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Scheme 1
Scheme 2
Scheme 3
Scheme 4
Scheme 5
Scheme 6
Scheme 7
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  1. F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Cancer J. Clin. 68, 394 (2018)

    Article  Google Scholar 

  2. C. Fitzmaurice, JAMA Oncol. 3, 524 (2017)

    Article  PubMed  Google Scholar 

  3. R.I.M. Yunos, N.S.A. Mutalib, F.Y.F. Tieng, N. Abu, R. Jamal, Biomolecules 10, 476 (2020)

    Article  CAS  Google Scholar 

  4. K.E. Sleeman, M. de Brito, S. Etkind, K. Nkhoma, P. Guo, I.J. Higginson, B. Gomes, R. Harding, Lancet Glob. Health 7, e883 (2019)

    Article  PubMed  PubMed Central  Google Scholar 

  5. O. Samuel, A. Solaz, L. Toulemon, Population 72, 221 (2017)

    Article  Google Scholar 

  6. V. Schirrmacher, Int. J. Oncol. 54, 407 (2019)

    CAS  PubMed  Google Scholar 

  7. A.R. Ferreira, D. Meglio, B. Pistilli, S.A. Gbenou, M. El-Mouhebb, S. Dauchy, P.A. Charles, A.H. Partridge, S. Delaloge, S. Michiels, F. Andre, I. Vaz-Luis, Oncology 30, 1784 (2019)

    CAS  Google Scholar 

  8. C.Y. Huang, D.T. Ju, C.F. Chang, P.M. Reddy, B.K. Velmurugan, Biomedicine 7, 12 (2017)

    Article  Google Scholar 

  9. R. Ralhan, J. Kaur, Expert Opin. Ther. Pat. 17, 1061 (2007)

    Article  CAS  Google Scholar 

  10. R.K. Singha, D.N. Prasada, T.R. Bhardwaj, Arab. J. Chem. 10, 420 (2017)

    Article  Google Scholar 

  11. G. Sun, T. Fan, L. Zhao, Y. Zhou, R. Zhong, Future Med. Chem. 9, 403 (2017)

    Article  CAS  PubMed  Google Scholar 

  12. L.G. Magalhaes, L.L.G. Ferreira, A.D. Andricopulo, An. Acad. Bras. Cienc. 90, 1233–1250 (2018)

    Article  CAS  PubMed  Google Scholar 

  13. T. Isah, Pharmacogn. Rev. 10, 90 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. M. Mehrmohamadi, S.H. Jeong, J.W. Locasale, Cancer Metab. 5, 2 (2017)

    Article  Google Scholar 

  15. A. Luengo, D.Y. Gui, M.G.V. Heiden, Cell Chem. Biol. 21, 1161 (2017)

    Article  Google Scholar 

  16. A.T. Odularu, P.A. Ajibade, J.Z. Mbese, O.O. Oyedeji, J. Chem. 2019, 1 (2019)

    Article  Google Scholar 

  17. A. Quarta, M. Amorín, M.J. Aldegunde, L. Blasi, A. Ragusa, S. Nitti, G. Pugliese, G. Gigli, J.R. Granja, T. Pellegrino, Nanoscale 11, 23482 (2019)

    Article  PubMed  Google Scholar 

  18. K.E. Hevener, T.A. Verstak, K.E. Lutat, D.L. Riggsbee, J.W. Mooney, Acta Pharm. Sin. B. 8, 844 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  19. S. Kaufmann, Curr. Top. Med. Chem. 19, 713 (2019)

    Article  Google Scholar 

  20. J.V.M. Gowan, R. Chung, A. Maulik, I. Piotrowska, J.M. Walker, D.M. Yellon, Cardiovasc. Drugs Ther. 31, 63 (2017)

    Article  Google Scholar 

  21. R.J. Andrade, G.P. Aithal, E.S. Bjornsson, N. Kaplowitz, G.A.K. Ublick, D. Larrey, T.H. Karlsen, J. Hepatol. 70j, 1222 (2019)

    Article  Google Scholar 

  22. A.D. Ricart, Ann. Oncol. 28, 1681 (2017)

    Article  Google Scholar 

  23. A. Sanagawa, Y. Hotta, T. Kataoka, Y. Maeda, M. Kondo, Y. Kawade, Y. Ogawa, R. Nishikawa, M. Tohkin, K. Kimura, Cancer Med. 7, 2269 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  24. J. Małyszko, K. Kozłowska, L. Kozłowski, J. Małyszko, Nephrol. Dial. Transplant. 32, 924 (2017)

    PubMed  Google Scholar 

  25. G.T.M. Sales, R.D. Foresto, REV. Assoc. Med. Bras. 66, 82 (2020)

    Article  Google Scholar 

  26. Z. Zafar, C. Vogler, T. Hudali, M. Bhattarai, Clin. Med. Res. 17, 29 (2019)

    Article  PubMed  PubMed Central  Google Scholar 

  27. A. Rossi, M.C. Fortuna, G. Caro, G. Pranteda, V. Garelli, U. Pompili, M. Carlesimo, J. Cosmet. Dermatol. 16, 537 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  28. M.B. Meads, L.A. Hazlehurst, W.S. Dalton, Clin. Cancer Res. 14, 2619 (2008)

    Article  Google Scholar 

  29. P.S. Sharma, R. Sharma, R. Tyagi, Curr. Cancer Drug Targets 8, 53 (2008)

    Article  CAS  PubMed  Google Scholar 

  30. K.S. Bhullar, N.O. Lagarón, E.M.M. Gowan, I. Parmar, A. Jha, B.P. Hubbard, H.P.V. Rupasinghe, Mol. Cancer 17, 48 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  31. J.A. Endicott, M.E.M. Noble, L.N. Johnson, Annu. Rev. Biochem. 81, 587 (2012)

    Article  CAS  PubMed  Google Scholar 

  32. S.H. Han, J.H. Chung, J. Kim, K.S. Kim, Y.S. Han, Onco. Lett. 13, 3681 (2017)

    Article  CAS  Google Scholar 

  33. Z. Koledova, A. Krämer, L.R. Kafkova, V. Divoky, Stem Cells Dev. 19, 1663 (2010)

    Article  CAS  PubMed  Google Scholar 

  34. I. Neganova, F. Vilell, S.P. Atkinson, M. Lloret, J.O.F. Passos, T.V. Zglinicki, J.E. Oconnor, D. Burks, R. Jones, L. Armstrong, M. Lako, Stem Cells 29, 651 (2011)

    Article  CAS  PubMed  Google Scholar 

  35. L. Ding, J. Cao, W. Lin, H. Chen, X. Xiong, H. Ao, M. Yu, J. Lin, Q. Cui, Int. J. Mol. Sci. 21, 1960 (2020)

    Article  CAS  PubMed Central  Google Scholar 

  36. Y.Y. Zhang, F. Zhang, Y.S. Zhang, K. Thakur, J.G. Zhang, Y. Liu, H. Kan, Z.J. We, J. Agric. Food Chem. 67, 7378 (2019)

    Article  CAS  PubMed  Google Scholar 

  37. K. Paruch, M.P. Dwyer, C. Alvarez, C. Brown, T.Y. Chan, R.J. Doll, K. Keertikar, C. Knutson, B. McKittrick, J. Rivera, R. Rossman, G. Tucker, T.O. Fischmann, A. Hruza, V. Madison, A.A. Nomeir, Y. Wang, E. Lees, D. Parry, N. Sgambellone, W. Seghezzi, L. Schultz, F. Shanahan, D. Wiswell, X. Xu, Q. Zhou, R.A. James, V.M. Paradkar, H. Park, L.R. Rokosz, T.M. Staufferc, T.J. Guzi, Bioorg. Med. Chem. Lett. 17, 6220 (2007)

    Article  CAS  PubMed  Google Scholar 

  38. M.S. Phoujdar, G.R. Aland, Int. J. Curr. Pharm. Res 9, 94 (2016)

    Article  Google Scholar 

  39. D.A. Heathcote, H. Patel, S.H.B. Kroll, P. Hazel, M. Periyasamy, M. Alikian, S.K. Kanneganti, A.S. Jogalekar, B. Scheiper, M. Barbazanges, A. Blum, J. Brackow, A. Siwicka, R.D.M. Pace, M.J. Fuchter, J.P. Snyder, D.C. Liotta, P.S. Freemont, E.O. Aboagye, R.C. Coombes, A.G.M. Barrett, S. Ali, J. Med. Chem. 53, 8508 (2010)

    Article  CAS  PubMed  Google Scholar 

  40. S.M. El-Moghazy, D.A. Ibrahim, N.M. Abdelgawad, N.A.H. Farag, A.S. El-Khouly, Sci. Pharm. 79, 429 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. A. Bondke, S. Kroll, A. Barrett, M. Fuchter, B. Slafer, S.A.C. Coombes, J.P. Snyde, Patent EB3107914A1, European patent office (2014)

  42. M. Kaliszczak, H. Patel, S.H.B. Kroll, L. Carroll, G. Smith, S. Delaney, D.A. Heathcote, A. Bondke, M.J. Fuchter, R.C. Coombes, A.G.M. Barrett, S. Ali, E.O. Aboagye, Br. J. Cancer 109, 2356 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. A. Gopalsamy, H. Yang, J.W. Ellingboe, H.R. Tsou, N. Zhang, E. Honores, D. Powell, M. Miranda, J.P. McGinnis, S.K. Rabindran, Bioorg. Med. Chem. Lett. 15, 1591 (2005)

    Article  CAS  PubMed  Google Scholar 

  44. O.M. Ahmed, M.A. Mohamed, R.R. Ahmed, S.A. Ahmed, Eur. J. Med. Chem. 44, 3519 (2009)

    Article  CAS  PubMed  Google Scholar 

  45. A.S. Hassan, T.S. Hafez, S.A.M. Osman, M.M. Ali, Turk. J. Chem. 39, 1102 (2015)

    Article  CAS  Google Scholar 

  46. H. Galons, N. Oumata, L. Meijer, Exp. Opin. Ther. Pat. 20, 377 (2010)

    Article  CAS  Google Scholar 

  47. D.S. Williamson, M.J. Parratt, J.F. Bower, J.D. Moore, C.M. Richardson, P. Dokurno, A.D. Cansfield, G.L. Francis, R.J. Hebdon, R. Howes, P.S. Jackson, A.M. Ockie, J.B. Murray, C.L. Nunns, J. Powles, A. Robertson, A.E. Surgenor, C.J. Torrance, Bioorg. Med. Chem. Lett. 15, 863 (2005)

    Article  CAS  PubMed  Google Scholar 

  48. S.K. Kumar, B.L. Plant, W.J. Chng, J. Zonder, N. Callander, R. Fonseca, B. Fruth, V. Roy, C. Erlichman, A.K. Stewart, Blood 125, 443 (2015)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. E.P. Jane, D.R. Premkumar, J.M. Cavaleri, P.A. Sutera, T. Rajasekar, I.F. Pollack, J. Pharmacol. Exp. Ther. 356, 354 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. N.H. Metwally, M.A. Badawy, D.S. Okpy, Chem. Pharm. Bull 63, 495 (2015)

    Article  Google Scholar 

  51. N.H. Metwally, F.M. Abdelrazek, S.M. Eldaly, Res. Chem. Intermed. 42, 1071 (2016)

    Article  CAS  Google Scholar 

  52. N.H. Metwally, E.A. Deeb, Bioorg. Chem. 77, 203 (2018)

    Article  CAS  PubMed  Google Scholar 

  53. N.H. Metwally, F.M. Abdelrazek, S.M. Eldaly, J. Heter. Chem. 55, 2668 (2018)

    Article  CAS  Google Scholar 

  54. N.H. Metwally, I.T. Radwan, W.S. El-Serwy, M.A. Mohamed, Bioorg. Chem. 84, 456 (2019)

    Article  CAS  PubMed  Google Scholar 

  55. N.H. Metwally, M.S. Mohamed, E.A. Ragb, Bioorg. Chem. 88, 102929 (2019)

    Article  CAS  PubMed  Google Scholar 

  56. N.H. Metwally, M.S. Mohamed, Bioorg. Chem. 99, 103438 (2019)

    Article  PubMed  Google Scholar 

  57. N.H. Metwally, S.O. Abdallah, M.M. Abdel Mohsen, Bioorg. Chem. 97, 103672 (2020)

    Article  CAS  PubMed  Google Scholar 

  58. R.A. Carboni, D.D. Coffman, E.G. Howard, J. Am. Chem. Soc. 80, 2838 (1958)

    Article  CAS  Google Scholar 

  59. F. Denizot, R. Lang, Methods 22, 271 (1986)

    Google Scholar 

  60. S.A. Shawali, A.H. Albar, Can. J. Chem. 64, 871 (1986)

    Article  CAS  Google Scholar 

  61. C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney, Adv. Drug Deliv. Rev. 23, 3 (1997)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt

    Nadia Hanafy Metwally, Mona Said Mohamed & Emad Abdullah Deeb

Authors
  1. Nadia Hanafy Metwally
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mona Said Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emad Abdullah Deeb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nadia Hanafy Metwally.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 1841 KB)

Supplementary file2 (PDF 321 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Metwally, N.H., Mohamed, M.S. & Deeb, E.A. Synthesis, anticancer evaluation, CDK2 inhibition, and apoptotic activity assessment with molecular docking modeling of new class of pyrazolo[1,5-a]pyrimidines. Res Chem Intermed 47, 5027–5060 (2021). https://doi.org/10.1007/s11164-021-04564-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11164-021-04564-x

Keywords

Search

Navigation